15 Oct
Princess Margaret Cancer Centre, University Health Network
Toronto
K.Y. Ho Chair in Prostate Cancer Research (Medical Oncologist)
Princess Margaret Cancer Centre, University Health Network
University Health Network- K.Y. Ho Chair in Prostate Cancer Research (Medical Oncologist), Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network
The Department of Medicine in the Temerty Faculty of Medicine at the University of Toronto and the Division of Medical Oncology and Hematology at the University Health Network (UHN) are seeking to recruit an energetic and innovative Medical Oncologist with expertise in Early Phase Therapeutics and Clinical Genomics. The primary focus of this position is GU cancers, and the appointed individual will hold the K.Y.
Ho Chair in Prostate Cancer Research.
The successful applicant will have a demonstrated passion for the medical care of cancer patients as well as a strong interest in teaching and/or quality improvement. The successful applicant will join a multidisciplinary team in the management of patients with solid tumour malignancies and will work in collaboration with the clinical genomics and early-phase clinical trials programs within a comprehensive cancer centre setting. In addition, the candidate will be expected to engage in clinical, translational, or basic research. Other responsibilities include teaching at the undergraduate and postgraduate levels.
The Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre is the largest comprehensive program of its kind in Canada. The program is supported by outstanding institutional infrastructure, pathology, medical imaging, molecular diagnostics and clinical genomics programs and,
by a wide medical and allied-health multidisciplinary team. The program supports extensive clinical, translational, and basic research initiatives including a large clinical trials program. Additionally, the Division of Medical Oncology and Hematology supports a comprehensive training program attracting both national and international fellows.
The Princess Margaret Cancer Centre includes the Princess Margaret Research Institute (formerly the Ontario Cancer Institute - OCI). This is a world-class basic and translational research institute with particular strengths in Genomics, Immunology, Stem Cell Biology, Cancer Biology, and Cell Therapeutics.
The close association between clinicians and scientists provides the opportunity for collaborations on disease biology and the development of innovative and informative translational studies, allowing the applicant to achieve the goal of bench-to-bedside medicine. In addition, the Princess Margaret Cancer Centre supports active and widely recognized clinical trials and drug development programs and maintains a state-of-the-art GMP cell processing facility. Princess Margaret Cancer Centre is affiliated with the University of Toronto, which is world-recognized for programs in areas including Biochemistry, Immunology, Stem Cell Biology, Genomics, Proteomics, and Cell Processing, among others. Princess Margaret Cancer Centre is also a teaching hospital dedicated to educating the world’s future top cancer experts.
Our role as an internationally respected teaching hospital keeps us and our students abreast of the latest medical developments and the most advanced technology.
The successful candidate must be a Medical Oncologist and be eligible for a full-time clinical academic appointment at the rank of Assistant Professor or higher. It is expected that the candidate will be hired into one of the University of Toronto Clinician Investigator, Clinician Teacher, or Clinician Quality & Innovation tracks. For applicants being considered for appointment as a Clinician Teacher, excellence will be assessed by the presence of scholarly contributions to teaching and education as evidenced by pedagogical innovation, curriculum development, experience in teaching at the undergraduate and graduate level and teaching awards. For Clinician Investigators,
scholarly excellence will be assessed by the presence of research grants, publications in leading journals, invited presentations at significant conferences, awards, accolades, and other related accomplishments. The applicant must also have or be eligible for registration with the College of Physicians and Surgeons of Ontario and hold MD and FRCPC qualifications and Medical Oncology (or equivalent) specialist designation. Academic rank, salary and contractual arrangements will be commensurate with the qualifications and experience of the successful candidate. A highly attractive remuneration package is available.
UHN is partnering with the executive search firm Perrett Laver on this search process. Further information,
including details of how to apply, can be downloaded at this link quoting reference 7540. For informal inquiries, please contact Hazel Levin at ******** . The deadline for application is November 1st, 2024, 12pm EST.
For more information on the Princess Margaret Cancer Centre and our world-recognized programs, visit: this link.
For more information about the Department of Medicine at the University of Toronto, please visit our website at this link. The Department of Medicine’s academic position descriptions can be viewed on this webpage: this link.
All qualified candidates are encouraged to apply; however, Canadians and permanent residents will be given priority.
Diversity Statement
The University of Toronto,
University Health Network and Sinai Health System are strongly committed to diversity within its community and especially welcomes applications from racialized persons/persons of colour, women, Indigenous/Aboriginal People of North America, persons with disabilities, LGBTQ2S+ persons, and others who may contribute to the further diversification of ideas.
Accessibility Statement
The University strives to be an equitable and inclusive community and proactively seeks to increase diversity among its community members. Our values regarding equity and diversity are linked with our unwavering commitment to excellence in the pursuit of our academic mission. The University is committed to the principles of the Accessibility for Ontarians with Disabilities Act (AODA). As such, we strive to make our recruitment,
assessment and selection processes as accessible as possible and provide accommodations as required for applicants with disabilities. If you require any accommodations at any point during the application and hiring process, please contact ******** .
#J-18808-Ljbffr
▶️ K.Y. Ho Chair in Prostate Cancer Research (Medical Oncologist)
🖊️ Princess Margaret Cancer Centre, University Health Network
📍 Toronto